Important Safety Information
- See KYZATREX prescribing information. Raleigh, NC: Marius Pharmaceuticals; 2022.
- Data on file. Raleigh, NC: Marius Pharmaceuticals, 2020.
Medically Supervised Rx Testosterone Replacement Therapy (TRT)
KYZATREX® (testosterone undecanoate) is an FDA-approved prescription oral softgel for adult men who have low or no testosterone due to certain medical conditions (such as hypogonadism). The safety and efficacy of KYZATREX in males less than 18 years old have not been established. Improper use may affect bone growth in children. KYZATREX is not meant for use by women. MangoRx’s Prime Protocol TRT Program includes FDA-approved prescription KYZATREX (testosterone undecanoate) capsules when medically appropriate, ongoing medical support for prescription renewals each month, dosage increase guidance, and lab work. TRT Rx Drug products require a blood diagnostic test and online consultation with a licensed healthcare provider who will determine if the medication is appropriate. Your clinician will make a treatment decision based on your medical history and overall health after the completion of a lab test and telehealth consultation. Prescription testosterone is a Schedule III controlled substance and requires medical monitoring for as long as you take the medication. Thoroughly review all warnings and essential safety information regarding prescription testosterone drugs. KYZATREX can increase blood pressure, which can increase the risk of having a heart attack or stroke and can increase risk of death due to a heart attack or stroke. Your risk may be greater if you have already had a heart attack or stroke or if you have other risk factors for heart attack or stroke. Please see the full Prescribing Information and Medication Guide for KYZATREX.